|Bid||0.00 x 3200|
|Ask||0.00 x 800|
|Day's Range||54.55 - 54.61|
|52 Week Range||53.84 - 55.28|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.68|
|Expense Ratio (net)||0.11%|
Fixed-income investors have been loath to pick up international debt exposure as foreign exchange currency swings can negate the upside potential and increase portfolio volatility. Mark McCarron, chief investment officer for Wescott Financial Advisory Group, warned of global diversification when it comes to bonds due to currency risk, CNBC reports. "Our fixed income exposure is almost exclusively in U.S. dollars," McCarron, told CNBC.
Italy's budgetary plans for the 2019 fiscal year have unnerved financial markets. The Lega/Five Star Movement governing coalition, which came into power with the promise of a comprehensive program of extra public expenditure, has approved a substantial upward revision to the 2019 budget deficit target to 2.4% of gross domestic product: 3 times higher than the 0.8% figure agreed by the previous administration with the European Commission. The spread between German and Italian bonds has widened but, crucially, so has that between Spain and Italy (see Exhibit 1).
Last week, the second-largest U.S. issuer of exchange traded funds added to its lineup of fixed income ETFs with the debut of the Vanguard Total World Bond ETF (NASDAQ: BNDW). BNDW's holdings are the aforementioned BND and the Vanguard Total International Bond ETF (NASDAQ: BNDX). “This structure enables the Vanguard Total World Bond ETF to achieve immediate scale by using existing exposure from the underlying ETFs and is expected to result in tighter bid-ask spreads and lower operating expenses than investing directly in the benchmark’s constituents,” Pennsylvania-based Vanguard said in a statement.
Vanguard has rounded out its global fixed-income ETF suite with a new low-cost world bond ETF of ETFs that combines the global investment-grade universe. On Thursday, Vanguard launched the Vanguard Total World Bond ETF (NasdaqGM:BNDW) , which has a 0.09% expense ratio. The Vanguard Total World Bond ETF tries to reflect the performance of the Bloomberg Barclays Global Aggregate Float Adjusted Composite Index, which is comprised of investment-grade U.S. bonds and investment-grade non-U.S. dollar-denominated bonds taken from the Bloomberg Barclays U.S. Aggregate Float Adjusted Index and the Bloomberg Barclays Global Aggregate ex-USD Float Adjusted RIC Capped Index (USD Hedged), according to the fund's prospectus.
There’s a reason why money continues to flow into exchange-traded funds (ETFs) and other indexed products. Passive and indexed portfolios take the guesswork out of market-timing decisions because index funds own all the stocks within a certain market segment. Buying index funds on a regular schedule and sticking to that plan is one of the best things you do for your portfolio.
E*TRADE Financial Corporation today announced it has surpassed 250 commission-free ETFs with the addition of 46 ETFs from six providers to its Commission-Free ETF Pr
Vanguard, the second-largest U.S. issuer of exchange traded funds, said it has filed plans with the Securities and Exchange Commission to introduce the Vanguard Total World Bond ETF. Vanguard previously used the ETF of ETFs on one of its other bond ETFs. The Vanguard Total Corporate Bond ETF (VTC) debuted last year and holds the Vanguard Short-Term Corporate Bond ETF (VCSH) , Vanguard Intermediate-Term Corporate Bond ETF (VCIT) and Vanguard Long-Term Corporate Bond ETF (VCLT) .
Vanguard is gearing up to launch a new exchange-traded fund, announcing that it filed a preliminary registration statement with the Securities and Exchange Commission for the Vanguard Total World Bond ETF. "With the Total World Bond ETF, Vanguard will be the first firm to offer U.S. investors a single index product with exposure to the entire global investment-grade bond universe," said Vanguard Chief Investment Officer Greg Davis in the press release.
Index fund and exchange-traded fund (ETF) giant Vanguard said that it is planning to introduce the Vanguard Total World Bond ETF. The Vanguard Total World Bond ETF is expected to debut in the third quarter and will use an ETF of ETFs structure, an approach Vanguard previously applied with the Vanguard Total Corporate Bond ETF ( VTC). VTC, which debuted in November, holds Vanguard's other three corporate bond ETFs – the Vanguard Short-Term Corporate Bond ETF ( VCSH), Vanguard Intermediate-Term Corporate Bond ETF ( VCIT) and Vanguard Long-Term Corporate Bond ETF ( VCLT).
VALLEY FORGE, Pa., May 21, 2018 /PRNewswire/ -- Vanguard today filed a preliminary registration statement with the Securities and Exchange Commission for Vanguard Total World Bond ETF. The fund will be structured as an ETF of ETFs, investing directly in two existing low-cost ETFs: Vanguard Total Bond Market ETF (BND) and Vanguard Total International Bond ETF (BNDX). This structure enables the Vanguard Total World Bond ETF to achieve immediate scale by using existing exposure from the underlying ETFs and is expected to result in tighter bid/ask spreads and lower operating expenses than investing directly in the benchmark's constituents.
Year-to-date, three fixed income exchange-traded funds are among the top 10 ETFs in terms of new assets added. The iShares Short Treasury Bond ETF (NYSE: SHV ) and the iShares Core Aggregate Bond ETF (NYSE: ...
Global bond ETF investors that track the benchmark Bloomberg Barclays Global Aggregate Index may soon have exposure to Chinese renminbi-denominated government and policy bank securities. Bloomberg announced ...
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced the signing of the clinical trial agreement (CTA) for a Phase 2 clinical trial with the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The study is titled "A Phase II, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial to Assess the Safety, Reactogenicity, and Immunogenicity of Two Doses of Multimeric-001 (M-001) Followed by Seasonal Trivalent Influenza Vaccine." It is designed to evaluate the cell mediated immunity directly induced by BiondVax's universal flu vaccine candidate M-001, as well as M-001's priming effect to enhance the immunogenicity of current seasonal influenza vaccines.